Robert W. Ross
2021
In 2021, Robert W. Ross earned a total compensation of $4.7M as Chief Executive Officer, President and Director at Surface Oncology, a 318% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $294,000 |
|---|---|
| Option Awards | $3,871,867 |
| Salary | $506,250 |
| Other | $12,756 |
| Total | $4,684,873 |
Ross received $3.9M in option awards, accounting for 83% of the total pay in 2021.
Ross also received $294K in non-equity incentive plan, $506.3K in salary and $12.8K in other compensation.
Rankings
In 2021, Robert W. Ross' compensation ranked 2,822nd out of 12,415 executives tracked by ExecPay. In other words, Ross earned more than 77.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,822 out of 12,415 | 77th |
Division Manufacturing | 1,120 out of 5,505 | 80th |
Major group Chemicals And Allied Products | 442 out of 2,375 | 81st |
Industry group Drugs | 386 out of 2,096 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 112 out of 449 | 75th |
Source: SEC filing on April 26, 2022.
Ross' colleagues
We found three more compensation records of executives who worked with Robert W. Ross at Surface Oncology in 2021.